Issued Patents All Time
Showing 25 most recent of 27 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12415865 | Antibody molecules to C5AR1 and uses thereof | Karthik Viswanathan, Brian Booth, Andrew M. Wollacott, Gregory Babcock, Zachary Shriver | 2025-09-16 |
| 12338291 | Humanized antibody molecules to CD138 and uses thereof | Bharat Chaganty, Hedy Adari-Hall, Karthik Viswanathan, James R. Myette, Zachary Shriver +1 more | 2025-06-24 |
| 12297249 | Interleukin-2 agents and uses thereof | Scott Moore Carlson, Gregory Babcock, Zachary Shriver | 2025-05-13 |
| 12264203 | Humanized complement 5a receptor 1 antibodies and methods of use thereof | Karthik Viswanathan, Brian Booth, Andrew M. Wollacott, Gregory Babcock, Zachary Shriver +1 more | 2025-04-01 |
| 12227587 | Humanized complement 5A receptor 1 antibodies and methods of use thereof | Karthik Viswanathan, Brian Booth, Andrew M. Wollacott, Gregory Babcock, Zachary Shriver +1 more | 2025-02-18 |
| 12187807 | Antibody molecules to C5AR1 and uses thereof | Karthik Viswanathan, Brian Booth, Andrew M. Wollacott, Gregory Babcock, Zachary Shriver | 2025-01-07 |
| 12098178 | Methods of using interleukin-2 agents | Scott Moore Carlson, Gregory Babcock, Zachary Shriver, Thiago de Jesus Borges, Leonardo Vidal Riella | 2024-09-24 |
| 12091451 | Method of using antibody molecules to detect a proliferation-inducing ligand (APRIL) | James R. Myette, Zachary Shriver, Karthik Viswanathan, Andrew M. Wollacott, Hedy Adari-Hall +1 more | 2024-09-17 |
| 12084484 | Interleukin-2 agents and uses thereof | Scott Moore Carlson, Gregory Babcock, Zachary Shriver | 2024-09-10 |
| 11969476 | Antibody molecule-drug conjugates and uses thereof | Karthik Viswanathan, Kenneth Douglas Johnson, Obadiah J. Plante, James C. Delaney, Tyree J. Koch +2 more | 2024-04-30 |
| 11945868 | Antibody molecules to CD138 and uses thereof | Bharat Chaganty, Hedy Adari-Hall, Karthik Viswanathan, James R. Myette, Zachary Shriver | 2024-04-02 |
| 11912781 | Humanized complement 5A receptor 1 antibodies and methods of use thereof | Karthik Viswanathan, Brian Booth, Andrew M. Wollacott, Gregory Babcock, Zachary Shriver +1 more | 2024-02-27 |
| 11890319 | Antibody molecule-drug conjugates and uses thereof | Zachary Shriver, Obadiah J. Plante, Kai Li, Karthik Viswanathan, James C. Delaney +1 more | 2024-02-06 |
| 11858980 | Engineered polypeptides and uses thereof | Karthik Viswanathan, Brian Booth, Kristin Narayan, Andrew M. Wollacott | 2024-01-02 |
| 11773179 | Antibody molecules to C5aR1 and uses thereof | Karthik Viswanathan, Brian Booth, Andrew M. Wollacott, Gregory Babcock, Zachary Shriver | 2023-10-03 |
| 11168131 | Antibody molecule-drug conjugates and uses thereof | Obadiah J. Plante, James C. Delaney, Karthik Viswanathan, Zachary Shriver, Andrew M. Wollacott | 2021-11-09 |
| 11136385 | Methods of treating IgA nephropathy by administering an anti-APRIL (a proliferation-inducing ligand) antibody molecule | James R. Myette, Zachary Shriver, Karthik Viswanathan, Andrew M. Wollacott, Hedy Adari-Hall +1 more | 2021-10-05 |
| 10981982 | Nucleic acid molecules encoding antibodies to a proliferation-inducing ligand (APRIL) | James R. Myette, Zachary Shriver, Karthik Viswanathan, Andrew M. Wollacott, Hedy Adari-Hall +1 more | 2021-04-20 |
| 10968270 | Antibody molecules to a proliferation-inducing ligand (APRIL) | James R. Myette, Zachary Shriver, Karthik Viswanathan, Andrew M. Wollacott, Hedy Adari-Hall +1 more | 2021-04-06 |
| 10954296 | Method of using anti-APRIL (a proliferation-inducing ligand) antibodies to reduce IGA | James R. Myette, Zachary Shriver, Karthik Viswanathan, Andrew M. Wollacott, Hedy Adari-Hall +1 more | 2021-03-23 |
| 10385123 | Antibody molecules to a proliferation-inducing ligand (APRIL) | James R. Myette, Zachary Shriver, Karthik Viswanathan, Andrew M. Wollacott, Hedy Adari-Hall +1 more | 2019-08-20 |
| 9738726 | HER2-specific monoclonal antibodies and conjugates thereof | Dimiter S. Dimitrov, Zhongyu Zhu, Pradman K. Qasba | 2017-08-22 |
| 9222080 | Alpha 1-3 N-galactosylstransferase with altered donor specificities, compositions and methods of use | Pradman K. Qasba, Elizabeth Boeggeman, Marta Pasek | 2015-12-29 |
| 8703459 | Catalytic domains of beta(1,4)-galactosyltransferase I having altered metal ion specificity | Pradman K. Qasba, Elizabeth Boeggeman | 2014-04-22 |
| 8512991 | Beta 1,4-galactosyltransferases with altered donor and acceptor specificities, compositions and methods of use | Pradman K. Qasba, Elizabeth Boeggeman | 2013-08-20 |